Program Agenda

Pipeline 2012

Day 1
Session I: Are We Getting Closer
Session II: Early Drug Pipeline: Proof of Principle through IND
Session III: Early Device/Hybrid Product Pipeline: New Concepts and Initial Findings
Epilepsy Therapy Project Shark Tank Competition

Day 3
ETP Family Day: Pipeline Conference for General Public

Day 2
Session IV: Opportunities for the Future
Session V: Late Stage Devices
Session VI: Late Stage Drugs

With Thanks to Our Sponsors


Patrons: Cyberonics, Danny Did, Pfizer, Sunovion, Upsher-Smith


Supporters: Lundbeck, Medtronic, Supernus


Associates: Openconcept, UCB

Mission Advocate

Advocate: Neurovista

Our sessions are available as:

  • Audio Podcast an MP3 audio format
  • PDF Presentation as a PDF version of the Powerpoint presentation
  • Youtube Video or as a Youtube video

Day 1 - Thursday February 2, 2012

  2011 Epilepsy Pipeline Scorecard:
Pipeline Advances and Challenges
Daniel Friedman, MD
Session I: Are We Getting Closer?
  Where has epilepsy control improved in the last 30 years and what do we need today? Dieter Schmidt, MD
  Preclinical Testing: Getting out of the rut and how can we move faster? Henrik Klitgaard, PhD
  New paradigms in translational research Frances Jensen, MD
Session II: Early Drug Pipeline: Proof of Principle through IND
  Galanin Receptor-2 Based Therapy
NeuroAdjuvants, Inc.
Brian Klein, PhD
  NTP Pipeline Development
NeuroTherapeutics Pharma
Stephen D. Collins, MD. PhD
  Adenosine releasing brain implants For Epilepsy Therapy
Legacy Research Institute
Detlev Boison, PhD
  CPP-115, The Next Generation GABA-AT Inhibitor
Catalyst Pharmaceutical Partners, Inc.
Steven Miller, PhD
  C-21191: Anticonvulsant and Antinociceptive Properties of a Novel Sub-type Selective GABA-A Agonist
C-10068: Novel Morphinan Anticonvulsant with a Unique Pharmacological Profile
Concert Pharmaceuticals
Philip B. Graham, PhD.
  XeriJect Diazepan for Emergency Treatment of Seizures
Xeris Pharmaceuticals, Inc.
Steven Prestrelski, PhD
  Galanin gene delivery for temporal lobe epilepsy
Asklepios BioPharmaceutical, Inc.
Scott W.J. McPhee, PhD, MPH
  Huperzine Update Steven C. Schachter, MD
Session III: Early Device/Hybrid Product Pipeline: New Concepts and Initial Findings
  Improving Surgical Planning with Powerful Non-Invasive Dense Array EEG
Electrical Geodesics, Inc.
Ann Bunnenberg, PhD., JD
  Convenient and adaptable EEG Headset
Advanced Neurometrics, Inc.
Eric A. Duff
  ICV Dosing for Medication-Resistant Epilepsy Robert Fisher, MD, PhD
  Improving the development of promising drug candidates: preclinical solutions in a chronic mouse model of Mesial Temporal Lobe Epilepsy
SynapCell SAS
Melanie Langlois, PhD
Epilepsy Therapy Project Shark Tank Competition
Audio Podcast PDF Presentation
iPhone Seizure Alarm Charles Anderson
Audio Podcast PDF Presentation
Decoding Heart and Brain Signals for Prevention of SUDEP Chris Berka
Audio Podcast PDF Presentation
Sleep, Seizures, and Smart Shirts Matt T. Bianchi, MD, PhD, MMSc
Audio Podcast PDF Presentation
Protec Epilepsy Management System Megan Dickison
Audio Podcast PDF Presentation

Eyes as Window to Understand Epilepsy Rachel Kuperman, MD
Audio Podcast PDF Presentation
Automated Seizure Tracking & Recording - Using Video
Anoo Nathan

Day 2 - Friday February 3, 2012

  Epilepsy Study Consortium: Clinical Focus and Global Opportunity Jacqueline French, MD
Session IV: Opportunities for the Future
  Update on the NINDS Anticonvulsant Screening Program
H. Steve White, PhD
Session V: Late Stage Devices
  Responsive Neurostimulation for Epilepsy: Update on the RNS® System Clinical Trials
NeuroPace, Inc.
Martha J. Morrell MD
Visualase Laser Ablation in Neurosurgery
Visualase, Inc.
Bill Hoffman
  Transcranial Magnetic Stimulation in Clinical and Experimental Epilepsy Alexander Rotenberg, MD., PhD
  SmartWatch - Studies and Commercialization
Anoo Nathan
Session VI: Late Stage Drugs
  Lifecycle and Pipeline Projects Update: Vimpat, Keppra and Brivaracetam
UCB BioSciences, Inc.
Babak Boroojerdi, MD., PhD., MBA
  ONFI™ (Clobazam)
Lundbeck, US
Deborah Lee, MD., PhD
  YKP 3089
SK LifeScience, Inc.
S. James Lee, PhD
  VX-765 Jacqueline French, MD
  Closing remarks Roger Porter, MD

Day 3 - Saturday February 4, 2012 - ETP Family Day - Pipeline Conference for General Public

Welcome and Overview
The Reality of Epilepsy: State of the Art Steven C. Schachter MD,
Harvard Medical School, Boston MA

Panel: New Ways of Understanding the Brain and Epilepsy

  • Epilepsy as a Spectrum Disorder -Frances E. Jensen MD, Children's Hospital Boston, Boston MA
  • What Do Our Genes Tell Us? -Daniel H. Lowenstein MD, University of California, Dept of Neurology, San Francisco CA
Challenges Through Our Eyes Linda and Eric Warner
Minneapolis, MN
Amber Cooksey

Epilepsy Medications and Alternative Therapies on the Horizon Jacqueline French MD,
New York University, New York, NY
Steven C. Schachter MD
Harvard Medical School, Boston, MA

Panel Discussion: SUDEP – What do we know and what we need to talk about
  • Moderator: Joseph I. Sirven, MD, Mayo Clinic Arizona
  • Panelists: Jeffrey Buchhalter MD, PhD, Phoenix Children's Hospital, Phoenix AZ
  • Thomas Stanton, Danny Did Foundation
  • Tamzin Jeffs, SUDEP Aware
  • Lisa Lindahl, Entrepeneur
  • John Barry, MD, Stanford University, San Francisco CA
Devices and Surgery - Insights on Old and New Approaches Robert Fisher MD, PhD,
Stanford University, San Francisco CA
Samantha Chartrau, Grafton WI, Mentor,
Dietary Therapies and Wellness Elizabeth Thiele MD, PhD,
Massachusetts General Hospital, Boston MA;
Heidi Pask, Stoneboro PA, Mentor,

Reactor Panel: Insights from people with epilepsy

  • Moderator: Mimi Callanan RN, MSN, CNS, Stanford University, San Francisco, CA
  • Panelists: Dayna Breman, Los Angeles CA, Mentor,
  • D. Andrew Neff, Epilepsy Foundation of Northern California
  • Amber Cooksey
  • Chris Wilson, Albuquerque NM, Mentor,
Tools you can use in managing epilepsy, the role of social networking Patricia O. Shafer RN, MN, Beth Israel Deaconess Medical Center, Boston MA
Samantha Chartrau, Grafton WI, Mentor,
Patricia Barnes, New Sharon ME, Kevin's Pyramids
Questions, Closing Remarks